Share this article
Share this article
ST. PETERSBURG, Fla., June 3, 2021 /PRNewswire/ Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) (the Company ) announced today announced that on May 28, 2021 it received a notice ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Rule ) because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the Form 10-Q ) with the Securities and Exchange Commission ( SEC ). The Notice has no immediate effect on the listing or trading of the Company s securities on the Nasdaq Capital Market.
Cytocom CEO launches $115M SPAC – BizWest
bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Humacyte Announces Presentation by Principal Investigator Highlighting Clinical Experience with HAVs at Vascular Access Society of the Americas 2021 Spring Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Humacyte Leadership and Investigators to Present at Five Scientific Events in May
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.